{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:00:23Z","timestamp":1781154023760,"version":"3.54.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (AMI), conferring a high risk of systemic embolism. The management of LVT becomes exceedingly challenging when complicated by acute ischemic stroke and recent percutaneous coronary intervention (PCI), creating a therapeutic trilemma that lacks guideline-directed recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 27-year-old male with hypertension and diabetes presented with acute anterior ST-segment elevation myocardial infarction. Due to unsuccessful initial revascularization at a local hospital, he underwent delayed PCI on day 10 post-infarction at our center. On the first post-PCI day, he developed acute ischemic stroke, and echocardiography confirmed a mobile left ventricular thrombus as the embolic source. Navigating competing risks of stent thrombosis, hemorrhagic transformation, and recurrent embolism, an individualized six-phase antithrombotic strategy was implemented. This dynamic approach included acute-phase de-escalation, sequential anticoagulation with rivaroxaban followed by warfarin guided by thrombus response, stepwise de-escalation after complete revascularization, and eventual transition to long-term dual-pathway inhibition. Complete LVT resolution was achieved within 6\u00a0months, and the patient\u2019s neurological deficits fully recovered. No recurrent LVT, ischemic events, or major bleeding occurred during 18 months of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the complex management challenges of left ventricular thrombus and acute stroke following myocardial infarction, and underscores the value of individualized, phased antithrombotic strategies guided by dynamic risk assessment and serial imaging, rather than rigid adherence to single-disease guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1829968","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:39:40Z","timestamp":1781152780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From heart to brain: a Case Report of individualized antithrombotic management for left ventricular thrombus and stroke in a young patient with acute myocardial infarction"],"prefix":"10.3389","volume":"17","author":[{"given":"Jincheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuding","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Yan\u2019an Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Cardiovascular Disease of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Clinical Medicine Center for Cardiovascular Disease of Yunnan Province","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ehjcvp\/pvab057","article-title":"Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial","volume":"8","author":"Alcalai","year":"2022","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e940199","DOI":"10.12659\/AJCR.940199","article-title":"Resolution of left ventricular thrombus by vitamin K antagonist after failed treatment with apixaban in hemodialysis patient: case report","volume":"24","author":"Alenazi","year":"2023","journal-title":"Am. J. Case Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/neurolint17120198","article-title":"Early versus late anticoagulation for acute ischemic stroke in atrial fibrillation: a systematic review and meta-analysis of 17,380 patients","volume":"17","author":"Bafail","year":"2025","journal-title":"Neurol. Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12968-018-0494-3","article-title":"Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis","volume":"20","author":"Bulluck","year":"2018","journal-title":"J. Cardiovasc Magn. Reson"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1161\/CIRCULATIONAHA.108.778837","article-title":"Hypercoagulable states in cardiovascular disease","volume":"118","author":"Chan","year":"2008","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1182\/blood-2018-05-846592","article-title":"Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12916-024-03374-3","article-title":"Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry","volume":"22","author":"Dai","year":"2024","journal-title":"BMC Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12959-021-00259-w","article-title":"Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis","volume":"19","author":"Dalia","year":"2021","journal-title":"Thromb. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0140-6736(25)00439-8","article-title":"Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)","volume":"406","author":"Dehbi","year":"2025","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/heartjnl-2012-301962","article-title":"Left ventricular thrombus formation after acute myocardial infarction","volume":"98","author":"Delewi","year":"2012","journal-title":"Heart"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8156942","DOI":"10.1155\/2022\/8156942","article-title":"Recurrence of LV thrombus in a patient with severe ischaemic cardiomyopathy anticoagulated with apixaban","volume":"2022","author":"Farooqui","year":"2022","journal-title":"Case Rep. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223899","article-title":"Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel","volume":"2018","author":"Fredgart","year":"2018","journal-title":"BMJ Case Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jcmg.2016.12.006","article-title":"Timing of cardiac magnetic resonance imaging impacts on the detection rate of left ventricular thrombus after myocardial infarction","volume":"10","author":"Gellen","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/ehjacc\/zuaf173","article-title":"Dual antiplatelet therapy escalation and de-escalation","volume":"15","author":"Greco","year":"2026","journal-title":"Eur. Heart J. Acute Cardiovasc Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european society of cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tcm.2025.09.006","article-title":"Current insights and challenges in the management of left ventricular thrombus","volume":"36","author":"Katsouras","year":"2025","journal-title":"Trends Cardiovasc Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/american stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1160\/TH13-07-0587","article-title":"Individuals with coronary artery disease at a young age and features of the metabolic syndrome have an increased prothrombotic potential","volume":"111","author":"Kok","year":"2014","journal-title":"Thromb. Haemost."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2165\/00003088-200645120-00004","article-title":"Pharmacogenetics of target genes across the warfarin pharmacological pathway","volume":"45","author":"Lal","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1161\/cir.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American heart association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0003319718782807","article-title":"Is coronary artery ectasia a thrombotic disease?","volume":"70","author":"Liang","year":"2019","journal-title":"Angiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamacardio.2019.6175","article-title":"Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis","volume":"5","author":"Lopes","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1016\/j.jacl.2024.07.001","article-title":"Addressing residual risk beyond statin therapy: new targets in the management of dyslipidaemias-A report from the european society of cardiology cardiovascular round table","volume":"18","author":"Mach","year":"2024","journal-title":"J. Clin. Lipidol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/eurheartj\/ehx551","article-title":"Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction","volume":"39","author":"Maniwa","year":"2018","journal-title":"Eur. Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"Mccarthy","year":"2018","journal-title":"JAMA Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","article-title":"Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes","volume":"73","author":"Mccarthy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation\/american heart association task force on practice guidelines","volume":"61","author":"O'gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.12659\/AJCR.916114","article-title":"Simultaneous acute anterior ST-Elevation myocardial infarction and acute ischemic stroke of left middle cerebral artery: a case report","volume":"20","author":"Obaid","year":"2019","journal-title":"Am. J. Case Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e038589","DOI":"10.1161\/JAHA.124.038589","article-title":"Contemporary use and clinical significance of initial triple Versus double therapy after percutaneous coronary intervention for myocardial infarction in patients with atrial fibrillation","volume":"14","author":"Park","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"qyad041","DOI":"10.1093\/ehjimp\/qyad041","article-title":"A systematic review and meta-analysis of transthoracic echocardiogram vs. cardiac magnetic resonance imaging for the detection of left ventricular thrombus","volume":"1","author":"Phuah","year":"2023","journal-title":"Eur. Heart J. Imaging Methods Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijcard.2016.07.069","article-title":"Left ventricular thrombi after STEMI in the primary PCI era: a systematic review and meta-analysis","volume":"221","author":"Robinson","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102897","DOI":"10.1016\/j.rpth.2025.102897","article-title":"Impact of coronary revascularization on clinical outcomes of postacute myocardial infarction patients with left ventricular thrombus","volume":"9","author":"Seah","year":"2025","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"B39","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.jacadv.2025.101978","article-title":"Rivaroxaban vs warfarin in acute left ventricular thrombus following myocardial infarction: RIVAWAR, an open-label RCT","volume":"4","author":"Shah","year":"2025","journal-title":"JACC Adv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e006054","DOI":"10.1161\/JAHA.117.006054","article-title":"Outcomes and prognostic impact of prophylactic oral anticoagulation in anterior ST-Segment elevation myocardial infarction patients with left ventricular dysfunction","volume":"6","author":"Shavadia","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2005.08.021","article-title":"Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation","volume":"152","author":"Srichai","year":"2006","journal-title":"Am. Heart J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur. Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA auideline for the management of patients with chronic coronary disease: a report of the American heart association\/american college of cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jcmg.2015.06.017","article-title":"Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR","volume":"9","author":"Weinsaft","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.122.062762","article-title":"Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation (OPTION): a randomized, open-label, end point-blinded, noninferiority trial","volume":"147","author":"Wu","year":"2023","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cjco.2022.12.003","article-title":"Apixaban in patients with post-myocardial infarction left ventricular thrombus: a randomized clinical trial","volume":"5","author":"Youssef","year":"2023","journal-title":"CJC Open"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1829968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:39:57Z","timestamp":1781152797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1829968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":46,"alternative-id":["10.3389\/fphar.2026.1829968"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1829968","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1829968"}}